PATENT CLAIM ANALYSIS

Application Number: 16089235
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "167000"]

Abstract:
Methods for treating vitamin D insufficiency and secondary hyperparathyroidism in patients having CKD comprising administering repeat doses of 25-hydroxyvitamin D are disclosed. The methods comprise administering 25-hydroxyvitamin D in an amount effective to safely raise the patient's serum 25-hydroxyvitamin D level to greater than 90 ng/ml and/or to control the patient's serum ratio of 25-hydroxyvitamin D to 24,25-dihydroxyvitamin D to less than 20.

Claim (Index 8):
The method of any of  claims 1 - 7 , wherein the doses of 25-hydroxyvitamin D are administered as controlled release oral dosages.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 97.0
- Lexical Diversity: 1.45652
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15231357', '15358065', '12597224', '13244945', '15990354']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8321981365766359
- 35 USC 102 Novelty (BERT): 0.6281096631349327
- Combined Prediction Score: 0.8117892892324655
- Mean Citation Score: 517.0578820000002
- Max Citation Score: 529.7744
- Similarity Product: 447.767850203228

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test